✨ 2 results found - Searched 23315 records in 3ms.
Tesis
Kesintasan Pada Kanker Paru Karsinoma Bukan Sel Kecil Jenis Adenokarsinoma Dengan Mutasi Epidermal Growth Factor Receptor Yang Diterapi Dengan Tyrosin Kinase Inhibitor Selama ≥ 18 Bulan Dan Faktor-Faktor Yang Memengaruhinya Di Rumah Sakit Umum Pusat Persahabatan
2024 | BY Vira Weldimira - Sita Laksmi Andarini - Jamal Zaini- Survival in non-small cell carcinoma lung cancer of adenocarcinoma type with epidermal growth factor receptor mutation treated with tyrosine kinase inhibitors for ≥ 18 months and influencing factors at RSUP Persahabatan.
- Nomor Panggil T24614fk
Tesis
Angka tahan hidup pasien kangker paru kelompok bukan sel kecil non skuamosa yang mendapat terapi target Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor dan yang mendapat Kemoterapi lini pertama di Rumah sakit Persahabatan
2014 | BY Sita Laksmi Andarini - Kasum Supriadi - Achmad Hudoyo- The survival rate of nonsquamous by non small cell lung carcinoma patiens who are given by target therapy epidermal growth facttor receptor-tyrosin kinase inhibitors and those given by first-line kemotheraphy treatment at Persahabatan hospital.
- Nomor Panggil T14579fk